Background illustration for clinical trials search

Paid Clinical Trials New York City

Discover 4,033 paid clinical trials in New York City, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

for
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute,
Location: New York NY, Buffalo NY, Columbus OH, Chicago IL,
Sponsor: BlossomHill Therapeutics

Sex: All

Age: 18+

Code: NCT06501196

Phase1, Recruiting

A Dietary Study for People With Multiple Myeloma

for
Multiple Myeloma
Location: New York NY, Uniondale NY, Montvale NJ, Middletown NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07226609

Recruiting

Pilocarpine Use After Kahook Goniotomy

for
Glaucoma
Location: The Bronx NY
Sponsor: Montefiore Medical Center

Sex: All

Age: 30 - 70+

Code: NCT03933631

Phase3, Recruiting

Epco, Zanu, Ritux for R/R FL or MZL

for
Follicular Lymphoma, Lymphoma, Non-Hodgkin Lymphoma,
Location: New York NY, Boston MA, Columbus OH
Sponsor: Reid Merryman, MD

Sex: All

Age: 18+

Code: NCT06563596

Phase2, Recruiting

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

for
High-risk Neuroblastoma, Neuroblastoma, Childhood Neuroblastoma
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 1 - 19

Code: NCT06528496

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

for
Metastatic Non-small Cell Lung Cancer
Location: New York NY, Hackensack NJ, Uniondale NY, Montvale NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT04410796

Phase2, Recruiting

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

for
Locally Advanced Urothelial Carcinoma,
Location: Newark NJ, Livingston NJ, New Brunswick NJ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06524544

Phase3, Recruiting

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

for
Systemic Lupus Erythematosus (SLE)
Location: Brooklyn NY, West Long Branch NJ, Rockville MD, Ottawa,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 16+

Code: NCT07175285

Recruiting

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

for
Heart Failure - NYHA II - IV
Location: New York NY, Flushing NY, Morristown NJ,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT07069738

Recruiting

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

for
B-ALL, DLBCL, B ALL, Dlbcl-Ci, DLBCL Unclassifiable,
Location: New York NY, Rockville Centre NY, Montvale NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT04512716

Early_phase1, Recruiting

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

for
Diffuse Midline Glioma, H3 K27-Altered,
Location: New York NY, Valhalla NY, Philadelphia PA, Baltimore MD,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 21

Code: NCT04870944

Phase1, Phase2, Recruiting

A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

for
Advanced Cancer, Metastatic Solid Tumor
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 1 - 25

Code: NCT05004116

Phase1, Phase2, Recruiting

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

for
Mesothelin Positive, Mesothelin-Expressing Tumors,
Location: New York NY, Uniondale NY, Montvale NJ, Middletown NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06623396

Phase1, Recruiting

A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

for
Lymphoma
Location: Stony Brook NY, Philadelphia PA, Chicago IL, Orlando FL,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06624085

Phase1, Recruiting

A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

for
Advanced or Metastatic Adrenocortical Carcinoma,
Location: New York NY, Providence RI, Sarasota FL
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07189403

Phase1, Recruiting

The WiSE®-UP Study (The WiSE System Utilization & Performance Study)

for
Heart Failure
Location: New York NY, Hershey PA, Charlottesville VA,
Sponsor: EBR Systems, Inc.

Sex: All

Age: 22+

Code: NCT07098858

Recruiting

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

for
Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer
Location: New York NY, Philadelphia PA, Boston MA, Pittsburgh PA,
Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT03686124

Phase1, Phase2, Recruiting

BoxX-NoAF Clinical Trial

for
Post Operative Atrial Fibrillation,
Location: Manhasset NY, Baltimore MD, Pittsburgh PA, Montreal,
Sponsor: AtriCure, Inc.

Sex: All

Age: 65+

Code: NCT06989775

Recruiting

Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer

for
Urothelial Carcinoma
Location: New York NY, Rockville Centre NY, Montvale NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05239624

Phase2, Recruiting

Long-term Outcome After Vemurafenib / BRAF Inhibitors Interruption in Erdheim-chester Disease

for
Erdheim-Chester Disease
Location: New York NY
Sponsor: Groupe Hospitalier Pitie-Salpetriere

Sex: All

Age: 18+

Code: NCT02089724

Recruiting

New York City stands out as a location known for a diverse array of clinical trials, thanks to its extensive healthcare network and renowned medical research institutions. Leading centers such as Memorial Sloan Kettering Cancer Center, NYU Langone Health, Mount Sinai Health System, and Weill Cornell Medicine are at the forefront of pioneering studies across various fields. The city's rich combination of cutting-edge research facilities and a diverse population enhances the scope and impact of clinical trials conducted here.

Why choose New York City for clinical trials?

New York City is an exceptional choice for participating in clinical trials, renowned for its innovative research environment and strong emphasis on groundbreaking medical advancements, with prestigious institutions such as Memorial Sloan Kettering Cancer Center, NYU Langone Health, and Mount Sinai Health System at the forefront.

By participating in a clinical trial in New York City, you not only gain early access to cutting-edge treatments but also contribute to significant medical research that could shape future healthcare practices.

Common conditions studied in New York City

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in New York City